Close Menu

Why Not Use Both?

At Albin Paul's microarray blog, he announces that NimbleGen Systems and 454 Life Sciences have teamed up with Baylor College of Medicine to create “sequence capture” technology. The technique combines chips with next-gen sequencing, the end goal being to create a whole-genome human exome microarray that is faster and cheaper than using PCR for selective resequencing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.